Atlas Trials

Ivermectin as a Novel Therapy in COVID-19 Treatment

Clinical trial NCT04403555 · COMPLETED

Trial details

NCT number
NCT04403555
Sponsor
Tanta University
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
COVID
Start date
2020-06-01
Primary completion
2020-10-31
Enrollment
164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.